Kymera registers Phase 1 crossover trial testing oral formulations of KT-621Sep 16Trial updateKT-621Kymera Therapeutics, Inc.
Kymera moves up KT-621 atopic dermatitis data after fast enrollmentAug 5Quarterly updateKT-621Kymera Therapeutics, Inc.
Kymera registers long-term extension study for KT-621 in asthma patientsJun 30Trial updateKT-621Kymera Therapeutics, Inc.
Sign inSign in